SB 304-FN (2024): creating a cause of action for medical injuries resulting from the administration or prescription of gender transition surgery, cross-sex hormones, or puberty-blocking drugs and providing protections for individuals who receive medical detransitioning.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “SB 304-FN (2024): creating a cause of action for medical injuries resulting from the administration or prescription of gender transition surgery, cross-sex hormones, or puberty-blocking drugs and providing protections for individuals who receive medical detransitioning.” Granite Record, https://graniterecord.org/bill/2024/sb304. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). SB 304-FN (2024): creating a cause of action for medical injuries resulting from the administration or prescription of gender transition surgery, cross-sex hormones, or puberty-blocking drugs and providing protections for individuals who receive medical detransitioning. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2024/sb304
- Chicago
- Granite Record. “SB 304-FN (2024): creating a cause of action for medical injuries resulting from the administration or prescription of gender transition surgery, cross-sex hormones, or puberty-blocking drugs and providing protections for individuals who receive medical detransitioning.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2024/sb304.
- BibTeX
@misc{bill-2024-sb304, title = {SB 304-FN (2024): creating a cause of action for medical injuries resulting from the administration or prescription of gender transition surgery, cross-sex hormones, or puberty-blocking drugs and providing protections for individuals who receive medical detransitioning.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2024/sb304}, note = {Accessed 24 Oct. 2026} }
SB 304-FN (2024)
creating a cause of action for medical injuries resulting from the administration or prescription of gender transition surgery, cross-sex hormones, or puberty-blocking drugs and providing protections for individuals who receive medical detransitioning.
- Status: Referred for interim study
- Term: 2023-2024
- Senate committee: Judiciary
- Subject: Discrimination
The Story
It was introduced on January 3, 2024 and referred to the Senate Judiciary committee. The committee held a public hearing on January 16, 2024. The committee voted unanimously, 5–0, to recommend that the Senate study it after the session ends, and the report was placed on the consent calendar. On April 5, 2024 the Senate adopted “Refer to Interim Study” on a voice vote.
Sponsors
- Sen. Kevin Avard (R - SD12) (prime sponsor)
- Sen. Carrie Gendreau (R - SD1)
- Rep. Jim Kofalt (R - Hills 32)
- Rep. Maureen Mooney (R - Hills 12)
- Rep. Leah Cushman (R - Hills 28)
Hearings and Sessions
- January 16, 2024, 1:45 PM: hearing, Senate Judiciary, SH 100
Votes
- April 5, 2024, Senate: Refer to Interim Study — voice vote, passed
The Docket
- January 3, 2024: To Be Introduced 01/03/2024 and Referred to Judiciary
- January 16, 2024: Hearing: 01/16/2024, Room 100, SH, 01:45 pm
- April 5, 2024: Committee Report: Referred to Interim Study, 04/05/2024; Vote 5-0; CC
- April 5, 2024: Refer to Interim Study, MA, VV; 04/05/2024
Laws It Would Change
Related Bills
- HB 1664-FN (2024): relative to legal remedies for individuals who receive medical detransitioning.